Clinical Trial

Identification of Novel Skeletal Muscle-derived Factors That Promote Lipid Oxidation (Columbus)

Study acronym: Columbus
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to collect data to help researchers identify factors, such as certain proteins or genetic codes, that are secreted from muscle that are associated with the beneficial effects of exercise.
Protocol Amendment History 19 amendments
This ClinicalTrials.gov record has been amended 19 times since 2013-07-25; most recent amendment 2026-03-25.
Status change: Recruiting → Active, Not Recruiting 2014-11-18
Trial Details
NCT Number NCT01911091
Lead Sponsor AdventHealth Translational Research Institute
Collaborators: Sanford-Burnham Medical Research Institute, Takeda
Conditions Obesity, Disorder of Lipid Storage and Metabolism, Lipid Metabolism Disorders, Metabolic Disorder
Enrollment 56 participants
Start Date 2013-07
Primary Completion 2014-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-03-30